Company Filing History:
Years Active: 2006
Title: Helena Santos-Rosa: Innovator in Histone Methylation
Introduction
Helena Santos-Rosa is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of molecular biology, particularly in the area of histone methylation. Her work has implications for understanding transcriptional activity and gene regulation.
Latest Patents
Helena holds a patent for "Methods and means of histone methylation." This invention focuses on a previously uncharacterized group of histone H3 methylases that comprise a SET domain. These methylases are capable of methylating lysine 4 within the amino tail of histone H3 or within the histone H3 core. The importance of trimethylation by these methylases is highlighted, as it plays a crucial role in transcriptional activity. Helena's innovative approach has opened new avenues for research in epigenetics.
Career Highlights
Helena Santos-Rosa has established herself as a leading figure in her field. She is currently associated with Chroma Therapeutics Limited, where she continues to advance her research. Her work has garnered attention for its potential applications in therapeutic development and understanding complex biological processes.
Collaborations
Helena collaborates with notable scientists, including Tony Kouzarides, enhancing the impact of her research through shared expertise and insights.
Conclusion
Helena Santos-Rosa's contributions to histone methylation research exemplify the importance of innovation in molecular biology. Her patent and ongoing work at Chroma Therapeutics Limited reflect her commitment to advancing scientific knowledge and its applications.